Lmr Partners LLP Incyte Corp Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Incyte Corp stock. As of the latest transaction made, Lmr Partners LLP holds 161,200 shares of INCY stock, worth $11.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

161,200

Previous 163,400 1.35%

Holding current value

$11.2 Million

Previous $9.91 Million 7.57%

% of portfolio

0.1%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $16,396 - $19,622	286 New	286 $18,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $1.01 Million - $1.18 Million	-15,973 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $477,943 - $584,779	6,960 Added 77.22%	15,973 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $719,868 - $788,907	9,013 New	9,013 $758,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $248,033 - $300,134	-3,072 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $1.01 Million - $1.3 Million	-11,838 Reduced 79.4%	3,072 $276,000
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $1.11 Million - $1.62 Million	14,910 New	14,910 $1.55 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $855,330 - $1.16 Million	-13,538 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $542,833 - $711,391	7,432 Added 121.72%	13,538 $0
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $224,795 - $267,087	3,087 Added 102.25%	6,106 $453,000
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $221,956 - $267,785	3,019 New	3,019 $256,000
Q2 2018 Aug 03, 2018	SELL	$60.85 - $83.98 $384,267 - $530,333	-6,315 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$93.56 - $116.6 $274,879 - $342,570	2,938 Added 87.0%	6,315 $598,000
Q3 2017 Nov 09, 2017	BUY	$109.15 - $138.27 $368,599 - $466,937	3,377	3,377 $394,000

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account